IN2012DE00337A - - Google Patents
Info
- Publication number
- IN2012DE00337A IN2012DE00337A IN337DE2012A IN2012DE00337A IN 2012DE00337 A IN2012DE00337 A IN 2012DE00337A IN 337DE2012 A IN337DE2012 A IN 337DE2012A IN 2012DE00337 A IN2012DE00337 A IN 2012DE00337A
- Authority
- IN
- India
- Prior art keywords
- addition
- hydrolysis
- organic solvent
- solution
- required quantity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/377,047 US9872873B2 (en) | 2012-02-06 | 2012-03-29 | Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| PCT/IB2012/051513 WO2013117969A1 (en) | 2012-02-06 | 2012-03-29 | Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| EP12719066.8A EP2811984B1 (en) | 2012-02-06 | 2012-03-29 | Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis |
| IN337DE2012 IN2012DE00337A (ru) | 2012-02-06 | 2012-03-29 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN337DE2012 IN2012DE00337A (ru) | 2012-02-06 | 2012-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DE00337A true IN2012DE00337A (ru) | 2015-04-10 |
Family
ID=46028019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN337DE2012 IN2012DE00337A (ru) | 2012-02-06 | 2012-03-29 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9872873B2 (ru) |
| EP (1) | EP2811984B1 (ru) |
| IN (1) | IN2012DE00337A (ru) |
| WO (1) | WO2013117969A1 (ru) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
| CN103945902B (zh) | 2011-08-30 | 2018-07-20 | 阿斯泰克斯制药公司 | 地西他滨衍生物制剂 |
| US9801859B2 (en) * | 2012-09-18 | 2017-10-31 | Innopharma Licensing, Llc | Bendamustine formulations |
| US9765108B2 (en) | 2012-11-19 | 2017-09-19 | Shilpa Medicare Limited | Formulation of 5-azacytidine |
| CA2922099C (en) | 2013-08-27 | 2022-11-29 | Vasilios VOUDOURIS | Bendamustine pharmaceutical compositions |
| CN103585168A (zh) * | 2013-11-27 | 2014-02-19 | 哈尔滨誉衡药业股份有限公司 | 一种含有盐酸吉西他滨的药物组合物 |
| CN104739778A (zh) * | 2013-12-26 | 2015-07-01 | 山东新时代药业有限公司 | 一种注射用阿扎胞苷及其制备方法 |
| CA2941632C (en) | 2014-03-13 | 2023-10-24 | Vasilios VOUDOURIS | Bendamustine solid dispersions and continuous infusion |
| US20160095925A1 (en) * | 2014-10-01 | 2016-04-07 | Cadila Healthcare Limited | Stable formulation of azacitidine or salts thereof and their process for preparation |
| AU2016287585B2 (en) * | 2015-07-02 | 2020-12-17 | Otsuka Pharmaceutical Co., Ltd. | Lyophilized pharmaceutical compositions |
| CN105769775A (zh) * | 2016-03-24 | 2016-07-20 | 浙江华海药业股份有限公司 | 一种注射用阿扎胞苷的制备方法 |
| JP2020529409A (ja) | 2017-08-03 | 2020-10-08 | 大塚製薬株式会社 | 薬物化合物およびその精製方法 |
| CN108295034A (zh) * | 2018-03-29 | 2018-07-20 | 健进制药有限公司 | 一种注射用阿扎胞苷冻干粉针及其制备方法 |
| KR20190136284A (ko) * | 2018-05-30 | 2019-12-10 | 주식회사 삼양바이오팜 | 안정한 아자시티딘-함유 약제학적 조성물의 제조방법 |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684630A (en) | 1983-08-24 | 1987-08-04 | Repta Arnold J | Method of parenterally delivering drugs and related compositions |
| SG144165A1 (en) | 2003-07-25 | 2008-07-29 | Wyeth Corp | Cci-779 lyophilized formulations |
| US20060069060A1 (en) * | 2004-09-27 | 2006-03-30 | Sanjeev Redkar | Salts of decitabine |
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| CN101361718B (zh) | 2008-09-26 | 2013-08-28 | 深圳万乐药业有限公司 | 稳定的地西他滨冻干制剂的制备方法 |
| CN101584670B (zh) * | 2009-06-19 | 2011-04-20 | 江苏奥赛康药业有限公司 | 地西他滨冻干粉针剂 |
| US20110042247A1 (en) | 2009-06-25 | 2011-02-24 | Chandrasekhar Kocherlakota | Formulations of azacitidine and its derivatives |
| WO2011014541A1 (en) | 2009-07-30 | 2011-02-03 | Eagle Pharmaceuticals, Inc. | Stable formulations of azacitidine |
| WO2011103150A2 (en) * | 2010-02-18 | 2011-08-25 | Cephalon, Inc. | Lyophilized preparations of bendamustine |
| WO2012103226A2 (en) * | 2011-01-25 | 2012-08-02 | Dr. Reddy's Laboratories Ltd. | Bendamustine formulations |
-
2012
- 2012-03-29 EP EP12719066.8A patent/EP2811984B1/en active Active
- 2012-03-29 WO PCT/IB2012/051513 patent/WO2013117969A1/en active Application Filing
- 2012-03-29 US US14/377,047 patent/US9872873B2/en active Active
- 2012-03-29 IN IN337DE2012 patent/IN2012DE00337A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9872873B2 (en) | 2018-01-23 |
| US20140378407A1 (en) | 2014-12-25 |
| EP2811984A1 (en) | 2014-12-17 |
| EP2811984B1 (en) | 2015-08-26 |
| WO2013117969A1 (en) | 2013-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DE00337A (ru) | ||
| MA37400A1 (fr) | Composés hétérocyclyle en tant qu'inhibiteurs de mek | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| MD4575C1 (ru) | Новые пиррольные соединения, способ их получения и содержащие их фармацевтические композиции | |
| BR112019024747A2 (pt) | formulações de dose fixa | |
| EA201391758A1 (ru) | Спрессованная сердцевина для фармацевтической композиции, содержащая органические кислоты | |
| EA201591003A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| NZ729443A (en) | Heterocyclic modulators of lipid synthesis | |
| BR112013013950A2 (pt) | antagonista de lpa1 policíclico e usos dos mesmos | |
| IN2014MN02652A (ru) | ||
| IN2014DN03206A (ru) | ||
| EP2581376A4 (en) | MATRIC ACID / MATRIN DERIVATIVES AND MANUFACTURING METHOD AND USES THEREOF | |
| BR112013003439A2 (pt) | "inibidores de oxadiazol de produção de leucotrieno" | |
| CA2920410C (en) | Thienopiperidine derivative and use thereof | |
| MY179605A (en) | Use of benzimidazole-proline derivatives | |
| EA032951B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| HK1190643A1 (zh) | 用於胃腸外施用的吡咯藥物製劑及其製備方法和治療對吡咯化合物敏感的疾病的使用方法 | |
| TR201902057T4 (tr) | Tetrasiklin bileşikleri. | |
| EA201490573A1 (ru) | Соединение бензотиазолона | |
| IN2013DN02555A (ru) | ||
| MY169215A (en) | 3-o-heteroaryl-ingenol | |
| MX2015010486A (es) | Composicion masticable para administracion oral y proceso para preparar la misma. | |
| WO2016195194A3 (ko) | 신규한 tlr2 길항제 | |
| SG194711A1 (en) | Processes for preparing inhibitors of the hepatitis c virus |